ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Over the Counter (OTC) Analgesics Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-1A13723
Home | Market Reports | Health| Pharmacy| Drugs & Medications
Global Over the Counter OTC Analgesics Market Research Report 2023
BUY CHAPTERS

Global Over the Counter (OTC) Analgesics Market Research Report 2025

Code: QYRE-Auto-1A13723
Report
July 2025
Pages:94
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Pfizer Inc
Johnson & Johnson
Astrazeneca plc
Novartis
Sun Pharma
Bayer
Boehringer Ingelheim International GmbH
GlaxoSmithKline PLC
Sanofi SA
Takeda Pharmaceutical Company Limited
Reckitt Benckiser Group Plc.

Over the Counter (OTC) Analgesics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Over the Counter (OTC) Analgesics Market

Over the Counter (OTC) Analgesics Market

The global market for Over the Counter (OTC) Analgesics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Over the Counter (OTC) Analgesics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Over the Counter (OTC) Analgesics.
The Over the Counter (OTC) Analgesics market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Over the Counter (OTC) Analgesics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Over the Counter (OTC) Analgesics manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Over the Counter (OTC) Analgesics Market Report

Report Metric Details
Report Name Over the Counter (OTC) Analgesics Market
CAGR 5%
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Pfizer, Johnson & Johnson, AstraZeneca, Novartis, Sun Pharma, Bayer AG, Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Sanofi SA, Takeda Pharmaceutical Company Limited.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Over the Counter (OTC) Analgesics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Over the Counter (OTC) Analgesics in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Over the Counter (OTC) Analgesics Market report?

Ans: The main players in the Over the Counter (OTC) Analgesics Market are Pfizer, Johnson & Johnson, AstraZeneca, Novartis, Sun Pharma, Bayer AG, Boehringer Ingelheim International GmbH, GlaxoSmithKline PLC, Reckitt Benckiser Group PLC, Sanofi SA, Takeda Pharmaceutical Company Limited.

What are the Application segmentation covered in the Over the Counter (OTC) Analgesics Market report?

Ans: The Applications covered in the Over the Counter (OTC) Analgesics Market report are Retail Pharmacies, Hospital Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Over the Counter (OTC) Analgesics Market report?

Ans: The Types covered in the Over the Counter (OTC) Analgesics Market report are Tablet, Capsule, Other

Recommended Reports

Pain Relief Markets

OTC Drugs & Treatments

Analgesic & Anti-inflammatory

1 Over the Counter (OTC) Analgesics Market Overview
1.1 Product Definition
1.2 Over the Counter (OTC) Analgesics by Type
1.2.1 Global Over the Counter (OTC) Analgesics Market Value Comparison by Type (2024 VS 2031)
1.2.2 Tablet
1.2.3 Capsule
1.2.4 Other
1.3 Over the Counter (OTC) Analgesics by Application
1.3.1 Global Over the Counter (OTC) Analgesics Market Value by Application (2024 VS 2031)
1.3.2 Retail Pharmacies
1.3.3 Hospital Pharmacies
1.3.4 Online Pharmacies
1.4 Global Over the Counter (OTC) Analgesics Market Size Estimates and Forecasts
1.4.1 Global Over the Counter (OTC) Analgesics Revenue 2020-2031
1.4.2 Global Over the Counter (OTC) Analgesics Sales 2020-2031
1.4.3 Global Over the Counter (OTC) Analgesics Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Over the Counter (OTC) Analgesics Market Competition by Manufacturers
2.1 Global Over the Counter (OTC) Analgesics Sales Market Share by Manufacturers (2020-2025)
2.2 Global Over the Counter (OTC) Analgesics Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Over the Counter (OTC) Analgesics Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Over the Counter (OTC) Analgesics, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Over the Counter (OTC) Analgesics, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Over the Counter (OTC) Analgesics, Product Type & Application
2.7 Global Key Manufacturers of Over the Counter (OTC) Analgesics, Date of Enter into This Industry
2.8 Global Over the Counter (OTC) Analgesics Market Competitive Situation and Trends
2.8.1 Global Over the Counter (OTC) Analgesics Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Over the Counter (OTC) Analgesics Players Market Share by Revenue
2.8.3 Global Over the Counter (OTC) Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Over the Counter (OTC) Analgesics Market Scenario by Region
3.1 Global Over the Counter (OTC) Analgesics Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Over the Counter (OTC) Analgesics Sales by Region: 2020-2031
3.2.1 Global Over the Counter (OTC) Analgesics Sales by Region: 2020-2025
3.2.2 Global Over the Counter (OTC) Analgesics Sales by Region: 2026-2031
3.3 Global Over the Counter (OTC) Analgesics Revenue by Region: 2020-2031
3.3.1 Global Over the Counter (OTC) Analgesics Revenue by Region: 2020-2025
3.3.2 Global Over the Counter (OTC) Analgesics Revenue by Region: 2026-2031
3.4 North America Over the Counter (OTC) Analgesics Market Facts & Figures by Country
3.4.1 North America Over the Counter (OTC) Analgesics Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Over the Counter (OTC) Analgesics Sales by Country (2020-2031)
3.4.3 North America Over the Counter (OTC) Analgesics Revenue by Country (2020-2031)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Over the Counter (OTC) Analgesics Market Facts & Figures by Country
3.5.1 Europe Over the Counter (OTC) Analgesics Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Over the Counter (OTC) Analgesics Sales by Country (2020-2031)
3.5.3 Europe Over the Counter (OTC) Analgesics Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Over the Counter (OTC) Analgesics Market Facts & Figures by Region
3.6.1 Asia Pacific Over the Counter (OTC) Analgesics Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Over the Counter (OTC) Analgesics Sales by Region (2020-2031)
3.6.3 Asia Pacific Over the Counter (OTC) Analgesics Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Over the Counter (OTC) Analgesics Market Facts & Figures by Country
3.7.1 Latin America Over the Counter (OTC) Analgesics Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Over the Counter (OTC) Analgesics Sales by Country (2020-2031)
3.7.3 Latin America Over the Counter (OTC) Analgesics Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Over the Counter (OTC) Analgesics Market Facts & Figures by Country
3.8.1 Middle East and Africa Over the Counter (OTC) Analgesics Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Over the Counter (OTC) Analgesics Sales by Country (2020-2031)
3.8.3 Middle East and Africa Over the Counter (OTC) Analgesics Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Over the Counter (OTC) Analgesics Sales by Type (2020-2031)
4.1.1 Global Over the Counter (OTC) Analgesics Sales by Type (2020-2025)
4.1.2 Global Over the Counter (OTC) Analgesics Sales by Type (2026-2031)
4.1.3 Global Over the Counter (OTC) Analgesics Sales Market Share by Type (2020-2031)
4.2 Global Over the Counter (OTC) Analgesics Revenue by Type (2020-2031)
4.2.1 Global Over the Counter (OTC) Analgesics Revenue by Type (2020-2025)
4.2.2 Global Over the Counter (OTC) Analgesics Revenue by Type (2026-2031)
4.2.3 Global Over the Counter (OTC) Analgesics Revenue Market Share by Type (2020-2031)
4.3 Global Over the Counter (OTC) Analgesics Price by Type (2020-2031)
5 Segment by Application
5.1 Global Over the Counter (OTC) Analgesics Sales by Application (2020-2031)
5.1.1 Global Over the Counter (OTC) Analgesics Sales by Application (2020-2025)
5.1.2 Global Over the Counter (OTC) Analgesics Sales by Application (2026-2031)
5.1.3 Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2020-2031)
5.2 Global Over the Counter (OTC) Analgesics Revenue by Application (2020-2031)
5.2.1 Global Over the Counter (OTC) Analgesics Revenue by Application (2020-2025)
5.2.2 Global Over the Counter (OTC) Analgesics Revenue by Application (2026-2031)
5.2.3 Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2020-2031)
5.3 Global Over the Counter (OTC) Analgesics Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Company Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Pfizer Over the Counter (OTC) Analgesics Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Johnson & Johnson
6.2.1 Johnson & Johnson Company Information
6.2.2 Johnson & Johnson Description and Business Overview
6.2.3 Johnson & Johnson Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Johnson & Johnson Over the Counter (OTC) Analgesics Product Portfolio
6.2.5 Johnson & Johnson Recent Developments/Updates
6.3 AstraZeneca
6.3.1 AstraZeneca Company Information
6.3.2 AstraZeneca Description and Business Overview
6.3.3 AstraZeneca Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.3.4 AstraZeneca Over the Counter (OTC) Analgesics Product Portfolio
6.3.5 AstraZeneca Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Over the Counter (OTC) Analgesics Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Sun Pharma
6.5.1 Sun Pharma Company Information
6.5.2 Sun Pharma Description and Business Overview
6.5.3 Sun Pharma Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Sun Pharma Over the Counter (OTC) Analgesics Product Portfolio
6.5.5 Sun Pharma Recent Developments/Updates
6.6 Bayer AG
6.6.1 Bayer AG Company Information
6.6.2 Bayer AG Description and Business Overview
6.6.3 Bayer AG Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Bayer AG Over the Counter (OTC) Analgesics Product Portfolio
6.6.5 Bayer AG Recent Developments/Updates
6.7 Boehringer Ingelheim International GmbH
6.7.1 Boehringer Ingelheim International GmbH Company Information
6.7.2 Boehringer Ingelheim International GmbH Description and Business Overview
6.7.3 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Product Portfolio
6.7.5 Boehringer Ingelheim International GmbH Recent Developments/Updates
6.8 GlaxoSmithKline PLC
6.8.1 GlaxoSmithKline PLC Company Information
6.8.2 GlaxoSmithKline PLC Description and Business Overview
6.8.3 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.8.4 GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Product Portfolio
6.8.5 GlaxoSmithKline PLC Recent Developments/Updates
6.9 Reckitt Benckiser Group PLC
6.9.1 Reckitt Benckiser Group PLC Company Information
6.9.2 Reckitt Benckiser Group PLC Description and Business Overview
6.9.3 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Product Portfolio
6.9.5 Reckitt Benckiser Group PLC Recent Developments/Updates
6.10 Sanofi SA
6.10.1 Sanofi SA Company Information
6.10.2 Sanofi SA Description and Business Overview
6.10.3 Sanofi SA Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Sanofi SA Over the Counter (OTC) Analgesics Product Portfolio
6.10.5 Sanofi SA Recent Developments/Updates
6.11 Takeda Pharmaceutical Company Limited.
6.11.1 Takeda Pharmaceutical Company Limited. Company Information
6.11.2 Takeda Pharmaceutical Company Limited. Description and Business Overview
6.11.3 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Product Portfolio
6.11.5 Takeda Pharmaceutical Company Limited. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Over the Counter (OTC) Analgesics Industry Chain Analysis
7.2 Over the Counter (OTC) Analgesics Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Over the Counter (OTC) Analgesics Production Mode & Process Analysis
7.4 Over the Counter (OTC) Analgesics Sales and Marketing
7.4.1 Over the Counter (OTC) Analgesics Sales Channels
7.4.2 Over the Counter (OTC) Analgesics Distributors
7.5 Over the Counter (OTC) Analgesics Customer Analysis
8 Over the Counter (OTC) Analgesics Market Dynamics
8.1 Over the Counter (OTC) Analgesics Industry Trends
8.2 Over the Counter (OTC) Analgesics Market Drivers
8.3 Over the Counter (OTC) Analgesics Market Challenges
8.4 Over the Counter (OTC) Analgesics Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Pfizer Inc
Johnson & Johnson
Astrazeneca plc
Novartis
Sun Pharma
Bayer
Boehringer Ingelheim International GmbH
GlaxoSmithKline PLC
Sanofi SA
Takeda Pharmaceutical Company Limited
Reckitt Benckiser Group Plc.
List of Tables
 Table 1. Global Over the Counter (OTC) Analgesics Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Over the Counter (OTC) Analgesics Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Over the Counter (OTC) Analgesics Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Over the Counter (OTC) Analgesics Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Over the Counter (OTC) Analgesics Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Over the Counter (OTC) Analgesics Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Over the Counter (OTC) Analgesics Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Over the Counter (OTC) Analgesics Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Over the Counter (OTC) Analgesics, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Over the Counter (OTC) Analgesics, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Over the Counter (OTC) Analgesics, Product Type & Application
 Table 12. Global Key Manufacturers of Over the Counter (OTC) Analgesics, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Over the Counter (OTC) Analgesics by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Over the Counter (OTC) Analgesics as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Over the Counter (OTC) Analgesics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Over the Counter (OTC) Analgesics Sales by Region (2020-2025) & (K Units)
 Table 18. Global Over the Counter (OTC) Analgesics Sales Market Share by Region (2020-2025)
 Table 19. Global Over the Counter (OTC) Analgesics Sales by Region (2026-2031) & (K Units)
 Table 20. Global Over the Counter (OTC) Analgesics Sales Market Share by Region (2026-2031)
 Table 21. Global Over the Counter (OTC) Analgesics Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Over the Counter (OTC) Analgesics Revenue Market Share by Region (2020-2025)
 Table 23. Global Over the Counter (OTC) Analgesics Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Over the Counter (OTC) Analgesics Revenue Market Share by Region (2026-2031)
 Table 25. North America Over the Counter (OTC) Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Over the Counter (OTC) Analgesics Sales by Country (2020-2025) & (K Units)
 Table 27. North America Over the Counter (OTC) Analgesics Sales by Country (2026-2031) & (K Units)
 Table 28. North America Over the Counter (OTC) Analgesics Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Over the Counter (OTC) Analgesics Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Over the Counter (OTC) Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Over the Counter (OTC) Analgesics Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Over the Counter (OTC) Analgesics Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Over the Counter (OTC) Analgesics Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Over the Counter (OTC) Analgesics Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Over the Counter (OTC) Analgesics Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Over the Counter (OTC) Analgesics Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Over the Counter (OTC) Analgesics Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Over the Counter (OTC) Analgesics Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Over the Counter (OTC) Analgesics Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Over the Counter (OTC) Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Over the Counter (OTC) Analgesics Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Over the Counter (OTC) Analgesics Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Over the Counter (OTC) Analgesics Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Over the Counter (OTC) Analgesics Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Over the Counter (OTC) Analgesics Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Over the Counter (OTC) Analgesics Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Over the Counter (OTC) Analgesics Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Over the Counter (OTC) Analgesics Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Over the Counter (OTC) Analgesics Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Over the Counter (OTC) Analgesics Sales (K Units) by Type (2020-2025)
 Table 51. Global Over the Counter (OTC) Analgesics Sales (K Units) by Type (2026-2031)
 Table 52. Global Over the Counter (OTC) Analgesics Sales Market Share by Type (2020-2025)
 Table 53. Global Over the Counter (OTC) Analgesics Sales Market Share by Type (2026-2031)
 Table 54. Global Over the Counter (OTC) Analgesics Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Over the Counter (OTC) Analgesics Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Over the Counter (OTC) Analgesics Revenue Market Share by Type (2020-2025)
 Table 57. Global Over the Counter (OTC) Analgesics Revenue Market Share by Type (2026-2031)
 Table 58. Global Over the Counter (OTC) Analgesics Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Over the Counter (OTC) Analgesics Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Over the Counter (OTC) Analgesics Sales (K Units) by Application (2020-2025)
 Table 61. Global Over the Counter (OTC) Analgesics Sales (K Units) by Application (2026-2031)
 Table 62. Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2020-2025)
 Table 63. Global Over the Counter (OTC) Analgesics Sales Market Share by Application (2026-2031)
 Table 64. Global Over the Counter (OTC) Analgesics Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Over the Counter (OTC) Analgesics Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2020-2025)
 Table 67. Global Over the Counter (OTC) Analgesics Revenue Market Share by Application (2026-2031)
 Table 68. Global Over the Counter (OTC) Analgesics Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Over the Counter (OTC) Analgesics Price (US$/Unit) by Application (2026-2031)
 Table 70. Pfizer Company Information
 Table 71. Pfizer Description and Business Overview
 Table 72. Pfizer Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Pfizer Over the Counter (OTC) Analgesics Product
 Table 74. Pfizer Recent Developments/Updates
 Table 75. Johnson & Johnson Company Information
 Table 76. Johnson & Johnson Description and Business Overview
 Table 77. Johnson & Johnson Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Johnson & Johnson Over the Counter (OTC) Analgesics Product
 Table 79. Johnson & Johnson Recent Developments/Updates
 Table 80. AstraZeneca Company Information
 Table 81. AstraZeneca Description and Business Overview
 Table 82. AstraZeneca Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. AstraZeneca Over the Counter (OTC) Analgesics Product
 Table 84. AstraZeneca Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Novartis Over the Counter (OTC) Analgesics Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Sun Pharma Company Information
 Table 91. Sun Pharma Description and Business Overview
 Table 92. Sun Pharma Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Sun Pharma Over the Counter (OTC) Analgesics Product
 Table 94. Sun Pharma Recent Developments/Updates
 Table 95. Bayer AG Company Information
 Table 96. Bayer AG Description and Business Overview
 Table 97. Bayer AG Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Bayer AG Over the Counter (OTC) Analgesics Product
 Table 99. Bayer AG Recent Developments/Updates
 Table 100. Boehringer Ingelheim International GmbH Company Information
 Table 101. Boehringer Ingelheim International GmbH Description and Business Overview
 Table 102. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Boehringer Ingelheim International GmbH Over the Counter (OTC) Analgesics Product
 Table 104. Boehringer Ingelheim International GmbH Recent Developments/Updates
 Table 105. GlaxoSmithKline PLC Company Information
 Table 106. GlaxoSmithKline PLC Description and Business Overview
 Table 107. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. GlaxoSmithKline PLC Over the Counter (OTC) Analgesics Product
 Table 109. GlaxoSmithKline PLC Recent Developments/Updates
 Table 110. Reckitt Benckiser Group PLC Company Information
 Table 111. Reckitt Benckiser Group PLC Description and Business Overview
 Table 112. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Reckitt Benckiser Group PLC Over the Counter (OTC) Analgesics Product
 Table 114. Reckitt Benckiser Group PLC Recent Developments/Updates
 Table 115. Sanofi SA Company Information
 Table 116. Sanofi SA Description and Business Overview
 Table 117. Sanofi SA Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Sanofi SA Over the Counter (OTC) Analgesics Product
 Table 119. Sanofi SA Recent Developments/Updates
 Table 120. Takeda Pharmaceutical Company Limited. Company Information
 Table 121. Takeda Pharmaceutical Company Limited. Description and Business Overview
 Table 122. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Takeda Pharmaceutical Company Limited. Over the Counter (OTC) Analgesics Product
 Table 124. Takeda Pharmaceutical Company Limited. Recent Developments/Updates
 Table 125. Key Raw Materials Lists
 Table 126. Raw Materials Key Suppliers Lists
 Table 127. Over the Counter (OTC) Analgesics Distributors List
 Table 128. Over the Counter (OTC) Analgesics Customers List
 Table 129. Over the Counter (OTC) Analgesics Market Trends
 Table 130. Over the Counter (OTC) Analgesics Market Drivers
 Table 131. Over the Counter (OTC) Analgesics Market Challenges
 Table 132. Over the Counter (OTC) Analgesics Market Restraints
 Table 133. Research Programs/Design for This Report
 Table 134. Key Data Information from Secondary Sources
 Table 135. Key Data Information from Primary Sources
 Table 136. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Over the Counter (OTC) Analgesics
 Figure 2. Global Over the Counter (OTC) Analgesics Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Over the Counter (OTC) Analgesics Market Share by Type: 2024 & 2031
 Figure 4. Tablet Product Picture
 Figure 5. Capsule Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Over the Counter (OTC) Analgesics Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Over the Counter (OTC) Analgesics Market Share by Application: 2024 & 2031
 Figure 9. Retail Pharmacies
 Figure 10. Hospital Pharmacies
 Figure 11. Online Pharmacies
 Figure 12. Global Over the Counter (OTC) Analgesics Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Over the Counter (OTC) Analgesics Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Over the Counter (OTC) Analgesics Sales (2020-2031) & (K Units)
 Figure 15. Global Over the Counter (OTC) Analgesics Average Price (US$/Unit) & (2020-2031)
 Figure 16. Over the Counter (OTC) Analgesics Report Years Considered
 Figure 17. Over the Counter (OTC) Analgesics Sales Share by Manufacturers in 2024
 Figure 18. Global Over the Counter (OTC) Analgesics Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Over the Counter (OTC) Analgesics Players: Market Share by Revenue in Over the Counter (OTC) Analgesics in 2024
 Figure 20. Over the Counter (OTC) Analgesics Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Over the Counter (OTC) Analgesics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Over the Counter (OTC) Analgesics Sales Market Share by Country (2020-2031)
 Figure 23. North America Over the Counter (OTC) Analgesics Revenue Market Share by Country (2020-2031)
 Figure 24. U.S. Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Over the Counter (OTC) Analgesics Sales Market Share by Country (2020-2031)
 Figure 27. Europe Over the Counter (OTC) Analgesics Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Over the Counter (OTC) Analgesics Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Over the Counter (OTC) Analgesics Revenue Market Share by Region (2020-2031)
 Figure 35. China Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Taiwan Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Philippines Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Latin America Over the Counter (OTC) Analgesics Sales Market Share by Country (2020-2031)
 Figure 46. Latin America Over the Counter (OTC) Analgesics Revenue Market Share by Country (2020-2031)
 Figure 47. Mexico Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Brazil Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Argentina Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Middle East and Africa Over the Counter (OTC) Analgesics Sales Market Share by Country (2020-2031)
 Figure 51. Middle East and Africa Over the Counter (OTC) Analgesics Revenue Market Share by Country (2020-2031)
 Figure 52. Turkey Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Saudi Arabia Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. UAE Over the Counter (OTC) Analgesics Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 55. Global Sales Market Share of Over the Counter (OTC) Analgesics by Type (2020-2031)
 Figure 56. Global Revenue Market Share of Over the Counter (OTC) Analgesics by Type (2020-2031)
 Figure 57. Global Over the Counter (OTC) Analgesics Price (US$/Unit) by Type (2020-2031)
 Figure 58. Global Sales Market Share of Over the Counter (OTC) Analgesics by Application (2020-2031)
 Figure 59. Global Revenue Market Share of Over the Counter (OTC) Analgesics by Application (2020-2031)
 Figure 60. Global Over the Counter (OTC) Analgesics Price (US$/Unit) by Application (2020-2031)
 Figure 61. Over the Counter (OTC) Analgesics Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

OTC Oral Analgesics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global OTC Pain Medicines Market Research Report 2024
Global OTC Painkillers Market Research Report 2024
Over the Counter Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Opioid Analgesics Market Research Report 2025
Global Over the Counter Diagnostic Products Market Research Report 2024
Global Flavors into Over the Counter OTC Pharmaceuticals Market Insights Forecast to 2030
Pain Relief Medications Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Pain Relievers Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non opioid Topical Pain Relief Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Antipyretic and Analgesic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Pain Reliever Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Non opioid Pain Med Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
OTC Allergy Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Oral Analgesics Market Research Report 2024
Over The Counter Medicines for Sore Throat Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
OTC Cat Medicines Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
OTC Anti nausea Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Absorbable Pain Relievers for External Use Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions